Synthesis and Characterization of Some New 1,3,4-thiadiazole Compounds Derived from 3,4-(Methylenedioxy)cinnamic Acid and their Antimicrobial Activities

Author(s): Halit Muğlu , Mahmut Gür* , Maesm Ahmed Mohamed Ben Hsin , Nesrin Şener , Sevil Özkınalı , Osman Emre Özkan , İzzet Şener .

Journal Name: Letters in Organic Chemistry

Volume 16 , Issue 10 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Some new 1,3,4-thiadiazole compounds derived from 3,4-(methylenedioxy)cinnamic acid were synthesized in this study. Their structures were determined using UV-Vis, IR, 1H-NMR, and 13C-NMR spectroscopy. Moreover, the antibacterial activities of the new 1,3,4-thiadiazole derivatives were tested against Gram positive (Enterococcus durans, Bacillus subtilis, and Staphylococcus aureus) and gram negative (Salmonella typhimurium, Escherichia coli, Salmonella enteritidis, Salmonella infantis, Salmonella kentucky, Enterobacter aerogenes) bacteria using the disk diffusion method. Furthermore, their antifungal activity was tested against Candida albicans using the disk diffusion method. Some of the synthesized compounds (V, VII, XIII, and XIV) showed antibacterial activity against S. aureus. Also, one synthesized compound (VIII) showed antibacterial activity against E. coli, exhibiting 8 and 9 mm inhibition zones using 50 and 80 µL. One compound (IX) showed antibacterial activity against E. aerogenes, exhibiting a 12 mm inhibition zone using 80 µL. One compound (XIII) showed antibacterial activity against S. kentucky, exhibiting an inhibition zone of about 9 mm using 80 µL. Also, one compound (VII) showed antibacterial activity against E. durans, exhibiting 7, 7, and 8 mm inhibition zones using 30, 50, and 80 µL. None of the compounds (I-XV) showed antifungal activity against C. albicans. These results showed that some of the synthesized compounds could be used as antibacterial agents.

Keywords: 1, 3, 4-Thiadiazole, antimicrobial activity, IR and NMR spectroscopy, antibacterial activities, gram positive, gramnegative bacteria.

[1]
Alireza, A. Anti-Cancer Agents in Med. Chem., 2016, 16, 1301.
[2]
Gür, M.; Şener, N.; Kaştaş, Ç.A.; Özkan, O.E.; Muğlu, H.; Elmaswaria, M.A.M. J. Heterocycl. Chem., 2017, 54, 3578.
[3]
Aliabadi, A.; Eghbalian, E.; A., Kiani Iran. J. Basic Med. Sci., 2013, 16, 1133.
[4]
Mohammadi-Farania, A.; Heidarian, N.; Aliabadi, A.N. Iran. J. Pharm. Res., 2014, 13, 487.
[5]
Kaur, H.; Kumar, S.; Vishwakarma, P.; Sharma, M.; Saxena, K.K.; Kumar, A. Eur. J. Med. Chem., 2010, 45, 2777.
[6]
Patel, H.M.; Noolvi, M.N.; Sethi, N.S.; Gadad, A.K.; Cameotra, S.S. Arab. J. Chem., 2017, 10, 996.
[7]
Abdelhamid, A.O.; Gomha, S.M.; Shawali, A.S. J. Adv. Res., 2015, 6(6), 885.
[8]
Luszczki, J.J.; Karpińska, M.; Matysiak, J. Niewiadomy. A. Pharmacol. Rep., 2015, 67(3), 588.
[9]
Mopuri, D.; Pramod, N.; Latha, A.M.; Reddy, V.S. J. Pharm. Res., 2017, 11(8), 916.
[10]
Foroumadi, A.; Adibi, H.; Ardestani, S.K.; Shirooie, S.; Bozorgomid, A.; Jafari, A. Iran. J. Pharm. Res., 2017, 16(3), 904.
[11]
Balaji, K.; Bhatt, P.; Mallika, D.; Jha, A. Int. J. Pharm. Pharm. Sci., 2015, 7, 145.
[12]
Gomha, S.M.; Kheder, N.A.; Abdelhamid, A.O.; Mabkhot, Y.N. Molecules, 2016, 21, 1532.
[13]
Joseph, L.; George, M.; Mathews, P. J. Pharm. Chem. Biol. Sci., 2015, 3, 329.
[14]
Labanauskas, L.; Udrenaite, E.; Gaidelis, P.; Brukštus, A. Il Farmaco., 2004, 59, 255.
[15]
Skrzypek, A.; Matysiak, J.; Karpińska, M.M.; Niewiadomy, A. J. Enzyme Inhib. Med. Chem., 2013, 28, 816.
[16]
Varandas, L.S.; Fraga, C.A.M.; Miranda, A.L.P.; Barreiro, E. J. Lett. Drug Des. Discov, 2005, 2, 62.
[17]
Gür, M.; Muğlu, H.; Çavuş, M.S.; Güder, A.; Sayıner, H.S.; Kandemirli, F. J. Mol. Struct., 2017, 1134, 40.
[18]
Varvaresou, A.; Siatra-Papastaikoudi, T.; Tsotinis, A.; Tsantili-Kakoulidou, A.; Vamvakides, A. II Farmaco, 1998, 53, 320.
[19]
Ibrahim, D.A. Eur. J. Med. Chem., 2009, 44, 2776.
[20]
Karki, S.S.; Panjamurthy, K.; Kumar, S.; Nambiar, M.; Ramareddy, S.A.; Chiruvella, K.K.; Raghavan, S.C. Eur. J. Med. Chem., 2011, 46, 2109.
[21]
Lv, X.; Yang, L.; Fan, Z.; Bao, X. J. Saudi Chem. Soc., 2017, 22, 101.
[22]
Zhang, H.; Zhang, K.; Chen, L.; Li, Y.; Chai, L. J. Mol. Struct., 2017, 1145, 32.
[23]
Canlı, K.; Yetgin, A.; Akata, I.; Altuner, E.M. Complement Altern Med, 2016, 13(5), 178.
[24]
Özkan, O.E.; Zengin, G.; Akça, M.; Baloğlu, M.C.; Olgun, Ç.; Altuner, E.M.; Ateş, S.; Aktümsek, A.; Vurdu, H. RSC Advances, 2015, 5(89), 72950.
[25]
Muğlu, H.; Şener, N.; Emsaed, H.A.M.; Özkınalı, S.; Özkan, O.E.; Gür, M. J. Heterocycl. Chem., 2017, 1147, 151.
[26]
Hussain, S.; Sharma, J.; Amir, M. E-J. Chem., 2008, 5, 963.
[27]
Aly, A.A.; El-Sayed, R. Chem. Pap., 2006, 60, 56.
[28]
Bhatia, R.; Kaur, A. Der Pharma Chem, 2014, 6, 114.
[29]
Altuner, E.M.; Akata, I.; Canli, K. Fresenius Environ. Bull., 2012, 21, 3704.
[30]
Andrews, J.M.J. Antimicrob. Chemother., 2005, 56, 60.
[31]
Ilhan, S.; Savaroğlu, F.; Çolak, F.; İşçen, C.F.; Erdemgil, F.Z. Turk. J. Biol., 2006, 30, 149.
[32]
Canlı, K.; Yetgin, A.; Akata, I.; Altuner, E.M. Int. J. Pharm. Sci. Invent, 2016, 5, 1.
[33]
Altuner, E.M.; Canli, K. Kastamonu Uni. J. For. Fac, 2012, 12, 97.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 10
Year: 2019
Page: [825 - 836]
Pages: 12
DOI: 10.2174/1570178616666190118153815
Price: $58

Article Metrics

PDF: 21
HTML: 3